PL365985A1 - Proleki przeciwwirusowe - Google Patents

Proleki przeciwwirusowe

Info

Publication number: PL365985A1
Authority: PL; Poland
Prior art keywords: triazoloribonucleoside; prodrugs; administration; viral disease; disease conditions
Prior art date: 2000-03-15

Application number

PL01365985A

Other languages

English (en)

Inventor

Guangyi Wang

Kanda Ramasamy

Johnson Lau

Original Assignee

Ribapharm Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-15

Filing date

2001-03-15

Publication date

2005-01-24

2001-03-15 Application filed by Ribapharm Inc. filed Critical Ribapharm Inc.

2005-01-24 Publication of PL365985A1 publication Critical patent/PL365985A1/pl

Links

201000010099 disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
229940002612 prodrug Drugs 0.000 title 1
239000000651 prodrug Substances 0.000 title 1
230000003612 virological effect Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/14—Pyrrolo-pyrimidine radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/052—Imidazole radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/056—Triazole or tetrazole radicals

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Virology (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Tropical Medicine & Parasitology (AREA)
Epidemiology (AREA)
AIDS & HIV (AREA)
Pulmonology (AREA)
Transplantation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

PL01365985A 2000-03-15 2001-03-15 Proleki przeciwwirusowe PL365985A1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US18967200P	2000-03-15	2000-03-15
US09/594,410 US6495677B1 (en)	2000-02-15	2000-06-16	Nucleoside compounds

Publications (1)

Publication Number	Publication Date
PL365985A1 true PL365985A1 (pl)	2005-01-24

Family

ID=26885400

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL01366038A PL366038A1 (pl)	2000-03-15	2001-03-15	Związki nukleozydowe i ich zastosowanie
PL01365985A PL365985A1 (pl)	2000-03-15	2001-03-15	Proleki przeciwwirusowe

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL01366038A PL366038A1 (pl)	2000-03-15	2001-03-15	Związki nukleozydowe i ich zastosowanie

Country Status (18)

Country	Link
US (1)	US6495677B1 (pl)
EP (2)	EP1207890A4 (pl)
JP (2)	JP2004505889A (pl)
KR (2)	KR20030032927A (pl)
CN (2)	CN1424913A (pl)
AU (2)	AU5088101A (pl)
BR (2)	BR0109144A (pl)
CA (2)	CA2400370A1 (pl)
CZ (2)	CZ20023119A3 (pl)
DE (1)	DE20121305U1 (pl)
HU (2)	HUP0302334A2 (pl)
IL (1)	IL151073A0 (pl)
MX (2)	MXPA02008608A (pl)
NO (2)	NO20024355L (pl)
PL (2)	PL366038A1 (pl)
RU (2)	RU2002121628A (pl)
SK (2)	SK11502002A3 (pl)
WO (2)	WO2001068663A1 (pl)

Families Citing this family (98)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7638496B2 (en)	2000-02-15	2009-12-29	Valeant Pharmaceuticals North America	Nucleoside analogs with carboxamidine modified monocyclic base
JP2003532643A (ja)	2000-04-13	2003-11-05	フアーマセツト・リミテツド	肝炎ウイルス感染症を治療するための３’−または２’−ヒドロキシメチル置換ヌクレオシド誘導体
MY164523A (en)	2000-05-23	2017-12-29	Univ Degli Studi Cagliari	Methods and compositions for treating hepatitis c virus
PL359169A1 (pl)	2000-05-26	2004-08-23	Idenix (Cayman) Limited	Sposoby i kompozycje do leczenia infekcji flawiwirusowych i pestiwirusowych
US6815542B2 (en) *	2000-06-16	2004-11-09	Ribapharm, Inc.	Nucleoside compounds and uses thereof
DE10112926B4 (de) *	2001-03-13	2005-11-10	Schebo Biotech Ag	Verwendung von Aminooxyacetat zur Tumorbehandlung
AU2002330154A1 (en) *	2001-09-28	2003-04-07	Centre National De La Recherche Scientifique	Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
WO2003073989A2 (en) *	2002-02-28	2003-09-12	Biota, Inc.	Nucleoside 5'-monophosphate mimics and their prodrugs
NZ536116A (en) *	2002-04-03	2007-01-26	Topotarget Uk Ltd	Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors
CN101172993A (zh)	2002-06-28	2008-05-07	埃迪尼克斯(开曼)有限公司	用于治疗黄病毒感染的2′－c－甲基－3′－o－l－缬氨酸酯核糖呋喃基胞苷
KR20050035194A (ko) *	2002-06-28	2005-04-15	이데닉스 (케이만) 리미티드	플라비비리다에 감염 치료용 2'-ｃ-메틸-3'-ｏ-ｌ-발린에스테르 리보푸라노실 사이티딘
US7608600B2 (en)	2002-06-28	2009-10-27	Idenix Pharmaceuticals, Inc.	Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
EP1545545A4 (en)	2002-08-01	2008-09-03	Pharmasset Inc	COMPOUNDS WITH THE BICYCLO 4.2.1 NONAN SYSTEM FOR THE TREATMENT OF FLAVIVIRIDAE / I INFECTIONS
AU2003298658A1 (en)	2002-11-15	2004-06-15	Idenix (Cayman) Limited	2'-branched nucleosides and flaviviridae mutation
TWI332507B (en)	2002-11-19	2010-11-01	Hoffmann La Roche	Antiviral nucleoside derivatives
CN1742018A (zh) *	2002-12-10	2006-03-01	弗·哈夫曼-拉罗切有限公司	抗病毒的核苷衍生物
US7598373B2 (en)	2002-12-12	2009-10-06	Idenix Pharmaceuticals, Inc.	Process for the production of 2-C-methyl-D-ribonolactone
MXPA05006865A (es) *	2002-12-23	2005-12-12	Idenix Cayman Ltd	Proceso para la produccion de profarmacos 3'-nucleosidos.
BRPI0407781A (pt) *	2003-02-25	2006-02-14	Applied Research Systems	aplicação combinada de ribavirina e interferon beta em doenças desmielinizantes
JP2006524227A (ja) *	2003-03-28	2006-10-26	ファーマセット，インク．	フラビウイルス科ウイルス感染の治療のための化合物
RU2358979C2 (ru)	2003-05-30	2009-06-20	Фармассет, Инк.	Модифицированные фторированные аналоги нуклеозида
US6930093B2 (en) *	2003-07-10	2005-08-16	Valeant Research & Development	Use of ribofuranose derivatives against inflammatory bowel diseases
ATE478886T1 (de)	2003-07-25	2010-09-15	Idenix Pharmaceuticals Inc	Purin nucleoside für die behandlung von durch flavividrae verursachten krankheiten, einschliesslich hepatitis c
WO2005018330A1 (en) *	2003-08-18	2005-03-03	Pharmasset, Inc.	Dosing regimen for flaviviridae therapy
JP2007505070A (ja) *	2003-09-11	2007-03-08	エフ．ホフマン−ラ　ロシュ　アーゲー	抗ウイルス性ヌクレオシド誘導体を製造する方法
CA2537878A1 (en) *	2003-09-11	2005-03-17	F. Hoffmann-La Roche Ag	Polymorphic nucleoside compounds
US20050182252A1 (en)	2004-02-13	2005-08-18	Reddy K. R.	Novel 2'-C-methyl nucleoside derivatives
WO2005123087A2 (en)	2004-06-15	2005-12-29	Merck & Co., Inc.	C-purine nucleoside analogs as inhibitors of rna-dependent rna viral polymerase
US20060040944A1 (en) *	2004-06-23	2006-02-23	Gilles Gosselin	5-Aza-7-deazapurine derivatives for treating Flaviviridae
US20070265222A1 (en)	2004-06-24	2007-11-15	Maccoss Malcolm	Nucleoside Aryl Phosphoramidates for the Treatment of Rna-Dependent Rna Viral Infection
CN101023094B (zh)	2004-07-21	2011-05-18	法莫赛特股份有限公司	烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
ES2725457T3 (es)	2004-09-14	2019-09-24	Gilead Pharmasset Llc	Preparación de ribofuranosil pirimidinas y purinas 2'fluoro-2'-alquil-sustituidas u otras opcionalmente sustituidas y sus derivados
CN1314702C (zh) *	2004-11-11	2007-05-09	中国人民解放军军事医学科学院放射与辐射医学研究所	核苷类似物胆固醇衍生物
AU2006242475B2 (en)	2005-05-02	2011-07-07	Merck Sharp & Dohme Corp.	HCV NS3 protease inhibitors
AR057456A1 (es)	2005-07-20	2007-12-05	Merck & Co Inc	Inhibidores de la proteasa ns3 del vhc
US8278322B2 (en)	2005-08-01	2012-10-02	Merck Sharp & Dohme Corp.	HCV NS3 protease inhibitors
US7781576B2 (en)	2005-12-23	2010-08-24	Idenix Pharmaceuticals, Inc.	Process for preparing a synthetic intermediate for preparation of branched nucleosides
GB0609492D0 (en)	2006-05-15	2006-06-21	Angeletti P Ist Richerche Bio	Therapeutic agents
GB0612423D0 (en)	2006-06-23	2006-08-02	Angeletti P Ist Richerche Bio	Therapeutic agents
US20100129317A1 (en) *	2006-09-11	2010-05-27	Southern Research Institute	Azole nucleosides and use as inhibitors of rna and dna viral polymerases
US8138164B2 (en)	2006-10-24	2012-03-20	Merck Sharp & Dohme Corp.	HCV NS3 protease inhibitors
CN101583372A (zh)	2006-10-24	2009-11-18	默克公司	Hcv ns3蛋白酶抑制剂
CA2667165A1 (en)	2006-10-24	2008-05-02	Merck & Co., Inc.	Hcv ns3 protease inhibitors
JP5268927B2 (ja)	2006-10-27	2013-08-21	メルク・シャープ・アンド・ドーム・コーポレーション	Ｈｃｖｎｓ３プロテアーゼ阻害剤
WO2008057208A2 (en)	2006-10-27	2008-05-15	Merck & Co., Inc.	Hcv ns3 protease inhibitors
US8101595B2 (en)	2006-12-20	2012-01-24	Istituto di Ricerche di Biologia Molecolare P. Angletti SpA	Antiviral indoles
GB0625349D0 (en)	2006-12-20	2007-01-31	Angeletti P Ist Richerche Bio	Therapeutic compounds
GB0625345D0 (en)	2006-12-20	2007-01-31	Angeletti P Ist Richerche Bio	Therapeutic compounds
AU2007342367B2 (en)	2007-01-05	2012-12-06	Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A.	Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection
US7964580B2 (en)	2007-03-30	2011-06-21	Pharmasset, Inc.	Nucleoside phosphoramidate prodrugs
AU2008277442A1 (en)	2007-07-17	2009-01-22	Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa	Macrocyclic indole derivatives for the treatment of hepatitis C infections
CN101754974B (zh)	2007-07-19	2016-02-03	Msd意大利有限公司	作为抗病毒剂的大环化合物
TW200918099A (en)	2007-09-14	2009-05-01	Nitto Denko Corp	Drug carriers
CN102014911A (zh)	2008-04-28	2011-04-13	默沙东公司	Hcv ns3蛋白酶抑制剂
US8173621B2 (en)	2008-06-11	2012-05-08	Gilead Pharmasset Llc	Nucleoside cyclicphosphates
ES2392611T3 (es)	2008-07-22	2012-12-12	Merck Sharp & Dohme Corp.	Compuestos de quinoxalina macrocíclica como inhibidores de la proteasa NS3 del VHC
BRPI0923225A2 (pt)	2008-12-02	2016-10-04	Chiralgen Ltd	metodo para sintese de acidos nucleicos modificados no atomo de fosforo
MX2011006890A (es)	2008-12-23	2011-07-20	Pharmasset Inc	Analogos de nucleosidos.
AR074897A1 (es)	2008-12-23	2011-02-23	Pharmasset Inc	Fosforamidatos de nucleosidos
CL2009002206A1 (es)	2008-12-23	2011-08-26	Gilead Pharmasset Llc	Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
WO2010082050A1 (en)	2009-01-16	2010-07-22	Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A.	Macrocyclic and 7-aminoalkyl-substituted benzoxazocines for treatment of hepatitis c infections
GB0900914D0 (en)	2009-01-20	2009-03-04	Angeletti P Ist Richerche Bio	Antiviral agents
WO2010108140A1 (en)	2009-03-20	2010-09-23	Alios Biopharma, Inc.	Substituted nucleoside and nucleotide analogs
US8618076B2 (en)	2009-05-20	2013-12-31	Gilead Pharmasset Llc	Nucleoside phosphoramidates
TWI576352B (zh)	2009-05-20	2017-04-01	基利法瑪席特有限責任公司	核苷磷醯胺
EP2451461A4 (en)	2009-07-06	2013-05-29	Ontorii Inc	NOVEL NUCLEIC ACID PRODRUGS AND METHOD OF USE THEREOF
US8828930B2 (en)	2009-07-30	2014-09-09	Merck Sharp & Dohme Corp.	Hepatitis C virus NS3 protease inhibitors
US20110027229A1 (en)	2009-07-31	2011-02-03	Medtronic, Inc.	Continuous subcutaneous administration of interferon-alpha to hepatitis c infected patients
WO2011076923A1 (en)	2009-12-23	2011-06-30	Institut National De La Sante Et De La Recherche Medicale	Inhibitor for inosine monophosphate (imp) dehydrogenase and/or viral rna polymerase for treatment of hepatitis e
PL3290428T3 (pl)	2010-03-31	2022-02-07	Gilead Pharmasset Llc	Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
AP2012006535A0 (en)	2010-03-31	2012-10-31	Gilead Pharmasset Llc	Stereoselective synthesis of phosphorous containing actives
WO2012040127A1 (en)	2010-09-22	2012-03-29	Alios Biopharma, Inc.	Substituted nucleotide analogs
DK2620428T3 (da)	2010-09-24	2019-07-01	Wave Life Sciences Ltd	Asymmetrisk hjælpegruppe
ES2716158T3 (es)	2010-11-30	2019-06-10	Gilead Pharmasset Llc	2'-spiro-nucleótidos para el tratamiento de hepatitis C
CN107365339A (zh)	2011-07-19	2017-11-21	波涛生命科学有限公司	合成官能化核酸的方法
HRP20180237T4 (hr)	2011-09-16	2020-12-11	Gilead Pharmasset Llc	Metode za liječenje hcv-a
US9328138B2 (en)	2011-11-15	2016-05-03	Msd Italia S.R.L.	HCV NS3 protease inhibitors
US8889159B2 (en)	2011-11-29	2014-11-18	Gilead Pharmasset Llc	Compositions and methods for treating hepatitis C virus
EP2794630A4 (en)	2011-12-22	2015-04-01	Alios Biopharma Inc	SUBSTITUTED PHOSPHORTHIOAT NUCLEOTIDE ANALOGUE
KR102072041B1 (ko)	2011-12-22	2020-01-31	앨리오스 바이오파마 인크.	치환된 뉴클레오사이드, 뉴클레오타이드 및 그의 유사체
WO2013106344A1 (en)	2012-01-12	2013-07-18	Ligand Pharmaceuticals, Inc.	2 '-c-methyl nucleosides containing a cyclic phosphate diester of 1, 3-propanediol (2-oxo-[1, 3, 2]-dioxaphosphorinane) at position 5'
NZ631601A (en)	2012-03-21	2016-06-24	Alios Biopharma Inc	Solid forms of a thiophosphoramidate nucleotide prodrug
USRE48171E1 (en)	2012-03-21	2020-08-25	Janssen Biopharma, Inc.	Substituted nucleosides, nucleotides and analogs thereof
US9441007B2 (en)	2012-03-21	2016-09-13	Alios Biopharma, Inc.	Substituted nucleosides, nucleotides and analogs thereof
NZ630805A (en)	2012-03-22	2016-01-29	Alios Biopharma Inc	Pharmaceutical combinations comprising a thionucleotide analog
PT2861611T (pt)	2012-05-25	2016-10-11	Janssen Sciences Ireland Uc	Nucleósidos de espirooxetano de uracilo
WO2014010250A1 (en)	2012-07-13	2014-01-16	Chiralgen, Ltd.	Asymmetric auxiliary group
US9243022B2 (en)	2012-12-21	2016-01-26	Alios Biopharma, Inc.	Substituted nucleosides, nucleotides and analogs thereof
EP2950786B1 (en)	2013-01-31	2019-11-27	Gilead Pharmasset LLC	Combination formulation of two antiviral compounds
WO2014121418A1 (en)	2013-02-07	2014-08-14	Merck Sharp & Dohme Corp.	Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
WO2014121417A1 (en)	2013-02-07	2014-08-14	Merck Sharp & Dohme Corp.	Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
EA201690473A1 (ru)	2013-08-27	2017-03-31	ГАЙЛИД ФАРМАССЕТ ЭлЭлСи	Комбинированный состав двух противовирусных соединений
CN105829333A (zh)	2013-10-11	2016-08-03	艾丽奥斯生物制药有限公司	取代的核苷、核苷酸及其类似物
EP3094728B1 (en)	2014-01-16	2022-03-09	Wave Life Sciences Ltd.	Chiral design
EP3623364A1 (en)	2014-02-13	2020-03-18	Ligand Pharmaceuticals, Inc.	Prodrug compounds and their uses
CN106687118A (zh)	2014-07-02	2017-05-17	配体药物公司	前药化合物及其用途
WO2019139919A1 (en)	2018-01-09	2019-07-18	Ligand Pharmaceuticals, Inc.	Acetal compounds and therapeutic uses thereof
WO2021138540A1 (en)	2020-01-03	2021-07-08	Berg Llc	Polycyclic amides as ube2k modulators for treating cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3984396A (en)	1971-06-01	1976-10-05	Icn Pharmaceuticals, Inc.	1-(β,-D-ribofuranosyl)-1,2,4-triazole acid esters
USRE29835E (en)	1971-06-01	1978-11-14	Icn Pharmaceuticals	1,2,4-Triazole nucleosides
US3798209A (en)	1971-06-01	1974-03-19	Icn Pharmaceuticals	1,2,4-triazole nucleosides
US3991078A (en)	1971-06-01	1976-11-09	Icn Pharmaceuticals, Inc.	N-substituted 1,2,4-triazoles
US4093624A (en)	1977-01-31	1978-06-06	Icn Pharmaceuticals, Inc.	1,2,4-Thiadiazolidine-3,5-dione
JPS6426593A (en)	1987-07-21	1989-01-27	Asahi Glass Co Ltd	Nucleoside derivative
SK284054B6 (sk)	1996-10-16	2004-08-03	Icn Pharmaceuticals, Inc.	Substituované triazolové nukleozidy, farmaceutický prostriedok s ich obsahom a ich použitie

2000
- 2000-06-16 US US09/594,410 patent/US6495677B1/en not_active Expired - Lifetime
2001
- 2001-03-15 CA CA002400370A patent/CA2400370A1/en not_active Abandoned
- 2001-03-15 JP JP2001567753A patent/JP2004505889A/ja active Pending
- 2001-03-15 CN CN01806350A patent/CN1424913A/zh active Pending
- 2001-03-15 PL PL01366038A patent/PL366038A1/pl unknown
- 2001-03-15 DE DE20121305U patent/DE20121305U1/de not_active Expired - Lifetime
- 2001-03-15 EP EP01924208A patent/EP1207890A4/en not_active Withdrawn
- 2001-03-15 WO PCT/US2001/008713 patent/WO2001068663A1/en not_active Ceased
- 2001-03-15 HU HU0302334A patent/HUP0302334A2/hu unknown
- 2001-03-15 EP EP01920509A patent/EP1268504A1/en not_active Withdrawn
- 2001-03-15 JP JP2001566501A patent/JP2003530322A/ja active Pending
- 2001-03-15 WO PCT/US2001/008769 patent/WO2001068034A2/en not_active Ceased
- 2001-03-15 BR BRPI0109144-1A patent/BR0109144A/pt not_active IP Right Cessation
- 2001-03-15 KR KR1020027012034A patent/KR20030032927A/ko not_active Withdrawn
- 2001-03-15 MX MXPA02008608A patent/MXPA02008608A/es unknown
- 2001-03-15 CZ CZ20023119A patent/CZ20023119A3/cs unknown
- 2001-03-15 AU AU50881/01A patent/AU5088101A/en not_active Abandoned
- 2001-03-15 KR KR1020027012033A patent/KR20030062227A/ko not_active Withdrawn
- 2001-03-15 RU RU2002121628/04A patent/RU2002121628A/ru not_active Application Discontinuation
- 2001-03-15 BR BRPI0109143-3A patent/BR0109143A/pt not_active IP Right Cessation
- 2001-03-15 AU AU47556/01A patent/AU4755601A/en not_active Abandoned
- 2001-03-15 HU HU0301730A patent/HUP0301730A2/hu unknown
- 2001-03-15 SK SK1150-2002A patent/SK11502002A3/sk unknown
- 2001-03-15 PL PL01365985A patent/PL365985A1/pl unknown
- 2001-03-15 MX MXPA02008609A patent/MXPA02008609A/es unknown
- 2001-03-15 SK SK1152-2002A patent/SK11522002A3/sk not_active Application Discontinuation
- 2001-03-15 CZ CZ20023051A patent/CZ20023051A3/cs unknown
- 2001-03-15 CA CA002400043A patent/CA2400043A1/en not_active Abandoned
- 2001-03-15 RU RU2002121631/15A patent/RU2002121631A/ru not_active Application Discontinuation
- 2001-03-15 CN CN01806351A patent/CN1416431A/zh active Pending
2002
- 2002-08-05 IL IL151073A patent/IL151073A0/en unknown
- 2002-09-12 NO NO20024355A patent/NO20024355L/no not_active Application Discontinuation
- 2002-09-13 NO NO20024385A patent/NO20024385L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU4755601A (en)	2001-09-24
NO20024355D0 (no)	2002-09-12
PL366038A1 (pl)	2005-01-24
KR20030062227A (ko)	2003-07-23
EP1207890A4 (en)	2003-01-15
CZ20023051A3 (cs)	2003-04-16
BR0109144A (pt)	2006-02-21
DE20121305U1 (de)	2002-09-19
EP1268504A1 (en)	2003-01-02
HUP0301730A2 (hu)	2003-09-29
WO2001068034A2 (en)	2001-09-20
HUP0302334A2 (hu)	2003-10-28
MXPA02008608A (es)	2004-09-06
BR0109143A (pt)	2006-02-21
NO20024385L (no)	2002-11-13
CN1424913A (zh)	2003-06-18
RU2002121628A (ru)	2004-02-27
MXPA02008609A (es)	2004-09-06
NO20024355L (no)	2002-11-12
CZ20023119A3 (cs)	2003-05-14
JP2003530322A (ja)	2003-10-14
CA2400370A1 (en)	2001-09-20
WO2001068663B1 (en)	2002-02-14
AU5088101A (en)	2001-09-24
SK11502002A3 (sk)	2003-03-04
WO2001068663A1 (en)	2001-09-20
EP1207890A2 (en)	2002-05-29
IL151073A0 (en)	2006-12-31
SK11522002A3 (sk)	2003-04-01
US6495677B1 (en)	2002-12-17
WO2001068034A3 (en)	2002-03-21
CN1416431A (zh)	2003-05-07
RU2002121631A (ru)	2004-03-10
WO2001068034B1 (en)	2002-05-10
CA2400043A1 (en)	2001-09-20
KR20030032927A (ko)	2003-04-26
JP2004505889A (ja)	2004-02-26
NO20024385D0 (no)	2002-09-13

Publication	Publication Date	Title
HUP0200260A2 (en)	2002-06-29	Novel phosphorus-containing prodrugs, their preparation and their use
AU6861001A (en)	2002-01-02	1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders
IL151400A0 (en)	2003-04-10	Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use
AU5364601A (en)	2001-11-12	Non-invasive gene targeting to the brain
IL153214A0 (en)	2003-07-06	Compounds to treat alzheimer's disease
HUP0500165A2 (en)	2006-09-28	Chalcone derivatives and their use to treat diseases
PT1296974E (pt)	2009-11-03	Derivados 2-cianopirrolidina e sua utilização como medicamentos
ZA200210278B (en)	2003-12-19	3-azabicyclo(3.1.0)hexane derivatives useful in therapy.
PL352030A1 (en)	2003-07-28	Treatment to neurotic disorders
GB0004531D0 (en)	2000-04-19	The treatment of respiratory diseases
GB0001710D0 (en)	2000-03-15	Therapeutic treatment
IL132972A0 (en)	2001-03-19	Pharmaceutical compositions comprising acetylcholinesterase antisense deoxynucleotides for the treatment of muscular and neuromuscular disorders
HUP0202223A3 (en)	2002-11-28	Pseudomycin prodrugs, pharmaceutical compositions comprising thereof and their use
GB0009612D0 (en)	2000-06-07	Therapeutic formulations
AU2002215187A1 (en)	2002-04-29	S-adenosylmethionine and derivatives thereof for the treatment and prevention ofalzheimer's disease
AU2002360531A8 (en)	2003-06-23	Methods and compositions to treat cardiovascular disease using 1419, 58765 and 2201
AU2096002A (en)	2002-06-18	Therapeutic treatment
IL151019A0 (en)	2003-02-12	Microcompetition and human disease
IL151188A0 (en)	2003-04-10	Medicament for viral diseases
GB2345857B (en)	2000-12-06	Scissors-clip diathermy (SCD)
AU2001262952A1 (en)	2001-11-07	Fullerene-based drugs targeted to bone
AU4838301A (en)	2001-09-24	Treatment of disorders relating to the serotonergic system
FI963753A7 (fi)	1996-09-20	Uusi lääke hengitysteiden virustaudin hoitamiseksi
AU2001272902A1 (en)	2001-12-03	Treating musculoskeletal disorders using lp85 and analogs thereof
MXPA00012560A (es)	2003-08-20	Uso de interleucocina-11 para tratar desordenes gastrointestinales.